Personalized cancer vaccine promises remission

Drug Discovery Today

Volumn 8, Issue 15, 2003, Pages 657-658

  Sussman, Hillary E ^a  

^a NONE

Author keywords

Antigen presenting cells; Cancer biology; Cancer vaccines; Chronic myelogenous leukemia (CML); Dendritic cells; Drug Discovery; Heat shock protein; Pharmaceutical Science

Indexed keywords

AG 858; ALPHA INTERFERON; ANTINEOPLASTIC AGENT; BCR ABL PROTEIN; CANCER VACCINE; HEAT SHOCK PROTEIN 70; IMATINIB; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; UNCLASSIFIED DRUG;

ABDOMINAL DISTENSION; ANTIGEN PRESENTING CELL; APOPTOSIS; BLEEDING; BONE MARROW; BONE MARROW TRANSPLANTATION; CANCER CELL; CHROMOSOME 22; CHROMOSOME 9; CHROMOSOME MUTATION; CHRONIC MYELOID LEUKEMIA; CLINICAL FEATURE; CLINICAL TRIAL; DENDRITIC CELL; DNA MODIFICATION; DRUG MANUFACTURE; DRUG RESEARCH; FATIGUE; FUSION GENE; HUMAN; IMMUNE SYSTEM; LEUKEMIA CELL; LEUKOCYTE; MONONUCLEAR CELL; NIGHT SWEAT; ONCOGENE; PHILADELPHIA 1 CHROMOSOME; SHORT SURVEY; T LYMPHOCYTE; WEIGHT REDUCTION;

ANIMALS; CANCER VACCINES; HUMANS; NEOPLASMS; REMISSION INDUCTION;

EID: 0043123252     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(03)02794-6     Document Type: Short Survey

References (6)

1. Li, Z. et al. (2003) Combination of imatinib mesylate with autologous leukocyte-derived heat shock protein 70 vaccine for chronic myelogenous leukemia. American Society of Clinical Oncology Annual Meeting, 31 May -3 June 2003, Chicago, IL, USA (Abstract 664).
2. Faderl S., et al. Chronic myelogenous leukemia: biology and therapy. Ann. Int. Med. 131:1999;207-219.
3. May T. Gleevec: tailoring to fit. Drug Discov. Today. 8:2003;188-189.
4. Pinilla-Ibarz J. Vaccination of patients with chronic myelogenous leukemia with Bcr-Abl oncogene breakpoint fusion peptides generates specific immune responses. Blood. 95:2000;1781-1787.
5. Zeng Y., et al. Tumour-derived, chaperone-rich cell lysate activates dendritic cells and elicits potent antitumour immunity. Blood. 1:2003;4485-4491.
6. Goldman B. Turning a tumour into its own worst enemy. Drug Discov. Today. 8:2003;471-472.